Jason Haider
Founder and CEO @ Xenco Medical
Jason Haider is a Series A investor at Xenco Medical focused on Machine Learning and Artificial Intelligence. Jason Haider: Founder and CEO @ Xenco Medical
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jason Haider invests in
Stages Jason Haider invests in
Countries Jason Haider invests in
Investment Focus
Industry
- Machine Learning 2 (33%)
- Artificial Intelligence 2 (33%)
- Energy 1 (17%)
- Sensor 1 (17%)
- Bitcoin 1 (17%)
Stage
- Series A 1 (17%)
- Series B 1 (17%)
- Series C 1 (17%)
- Series D 1 (17%)
- Series E 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Phantom
|
Phantom is a digital wallet reimagined for DeFi and NFTs. Phantom makes it safe & easy for you to store, send, receive, stake, and swap tokens on the Solana blockchain. It was founded in 2021 and is based in San Francisco, California. | $150M / Series C / Jan 16, 2025 | |
Butlr
|
Butlr is an AI people-sensing platform using body heat to detect occupancy, headcount, body posture, and activity, and generate accurate, real-time, and historical spatial insights for healthcare and sustainable buildings. Their sensor technology detects human presence anonymously using low-resolution thermal data and advanced AI and machinelearning. | $38M / Series B / Aug 26, 2024 | |
Anthropic
|
Anthropic conducts AI research and develops AI products, including the Claude AI model family. The company focuses on building AI for human well-being, emphasizing safety in its research, policy work, and product design. Anthropic offers various Claude models, such as Opus and Sonnet, for AI-powered applications and custom experiences, supportingcoding and AI agents. | $884.1M / Secondary Market / Mar 22, 2024 | |
|
Anthropic
|
Anthropic conducts AI research and develops AI products, including the Claude AI model family. The company focuses on building AI for human well-being, emphasizing safety in its research, policy work, and product design. Anthropic offers various Claude models, such as Opus and Sonnet, for AI-powered applications and custom experiences, supportingcoding and AI agents. | $884.1M / Series E / Mar 22, 2024 | |
Mammoth Biosciences
|
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection with an easy and affordablepoint-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in South San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng Capital and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.Mammoth has also been working on developing a rapid COVID-19 test. | $150M / Series D / Sep 09, 2021 | |
Motiv Electric Trucks
|
Founded in 2009 and headquartered in the San Francisco Bay Area, Motiv Power Systems delivers medium-duty class 4-6 commercial battery-electric trucks and buses, along with charging infrastructure and guidance for deploying commercial fleets. Specializing in step vans, shuttle buses, and box trucks, Motiv is a leading provider of daily-usezero-emission vehicles for moving people and moving goods that are the “backbone of urban commerce” with 98% uptime and intense customer-driven focus. The company’s solutions not only offer fleets up to 85% operations and maintenance cost savings but also provide operators and riders a healthier and more comfortable experience without polluting the communities they serve. For more information about the company’s products, services or career opportunities, please visit motivps.com. | $46.7M / Series A / Sep 30, 2019 |
Co-Investors
Lightspeed Venture Partners
3 deals together
NFX
3 deals together
HOF Capital
2 deals together
Jane Street Capital
2 deals together
Manhattan Venture Partners (MVP)
2 deals together
Omidyar Network
2 deals together
About Xenco Medical
Headquartered in San Diego, CA, Xenco Medical is an American medical technology company committed to disruptive innovation for the purposes of creating a safer surgical environment. Developed through an extensive dialogue between materials science and mechanical engineering, Xenco Medical‘s single-use SETx Technology eliminates the expensive,cumbersome, and inefficient processes necessary for traditional spinal implant systems.
Xenco Medical Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jason Haider
Founder and CEO
|
|||
|
Alex Leyvas
Mechanical Design Engineer
|
|||
|
Eric Nguyen
Quality Processes Engineer
|
|||
|
George Muir
Research Associate
|
|||
|
Macy Lunes
Operations Associate
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Jason Haider invest in?
Jason Haider invests primarily in Machine Learning, Artificial Intelligence and Energy startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jason Haider last invest?
The most recent investment recorded for Jason Haider closed in Jan 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
